Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Advanced Malignancies Clinical Trials

A listing of Advanced Malignancies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (296) clinical trials

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or metastatic malignancies.  

Phase

People with myeloid leukemia are asked to participate in a research study being conducted by Albert Einstein College of Medicine.  

Phase N/A

People with metastatic malignancies are asked to participate in a research study being conducted by White Plains Hospital.  

Phase N/A

People with solid tumors are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

Children with advanced solid tumors and hematological malignancies are asked to participate in a research study being conducted by Cohen Children's Medical Center of New York.  

Phase N/A

People with solid tumors are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.  

Phase N/A

People with advanced malignancies are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.  This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02385 at the protocol-defined starting dose administered every 2 weeks (Q2W), with dose ...

Phase

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with advanced malignancies. This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02390 at the protocol-defined starting dose administered every 2 weeks (Q2W), with ...

Phase

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2

PAC-1 in combination with temozolomide (Component 2): after the MTD is established for single agent PAC-1 in Component 1, a modified-Fibonacci dose-escalation 3+3 design starts in Component 2, at a PAC-1 dose one level lower than the MTD of PAC-1 established in the single agent PAC-1 component (i.e., Component 1) ...

Phase